Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components

Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components

US Patent 7498156 · Granted Mar 3, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer vaccine compositions and methods of use thereof2025
Yarns and fabrics including modacrylic fibers2024
Reduction of contaminants in blood and blood products using photosensitizers and2015
Preparation of vaccines using photosensitizer and light2014
Removal of adenine during a pathogen reduction process in whole blood or red blo2014
Methods and compositions for the production of high concentration alloxazine sol2011
Methods for washing a red blood cell component and for removing prions therefrom2011
Induction of and maintenance of nucleic acid damage in pathogens using riboflavi2011
Induction of and maintenance of nucleic acid damage in pathogens using riboflavi2011
Induction of and maintenance of nucleic acid damage in pathogens using riboflavi2011
Preventing transfusion related complications in a recipient of a blood transfusi2011
Preventing transfusion related complications in a recipient of a blood transfusi2010